Showing results (71-80 of 156) with videos related to
Sort By:
Pageof 16
British Journal of Haematology|October 11, 2014
Volume of white matter hyperintensities is an independent predictor of intelligence quotient and processing speed in children with sickle cell diseaseVeronica van der Land, Channa T Hijmans, Marieke de Ruiter, et al.Haematologica|January 7, 2018
Desmopressin in moderate hemophilia A patients: a treatment worth consideringJanneke I Loomans, Marieke J H A Kruip, Manuel Carcao, et al.Journal of Thrombosis and Haemostasis : JTH|April 5, 2023
Poor correlation between biomarkers and MRI-detected joint damage in a cross-sectional study of persons with nonsevere hemophilia A (DYNAMO study)Fabienne R Kloosterman, Anne-Fleur Zwagemaker, Anne C Bay-Jensen, et al.Thrombosis and Haemostasis|November 20, 2015
The incidence and treatment of bleeding episodes in non-severe haemophilia A patients with inhibitorsAlice S van Velzen, Corien L Eckhardt, Nina Streefkerk, et al.Journal of Proteome Research|August 22, 2017
Differences between Platelets Derived from Neonatal Cord Blood and Adult Peripheral Blood Assessed by Mass SpectrometryEva Stokhuijzen, Johanna Maria Koornneef, Benjamin Nota, et al.BMJ Open|May 5, 2018
Identifying Children with HEreditary Coagulation disorders (iCHEC): a protocol for a prospective cohort studyEva Stokhuijzen, Margaret L Rand, Marjon H Cnossen, et al.Lancet (London, England)|January 29, 2013
The Transfusion Alternatives Preoperatively in Sickle Cell Disease (TAPS) study: a randomised, controlled, multicentre clinical trialJo Howard, Moira Malfroy, Charlotte Llewelyn, et al.British Journal of Haematology|December 23, 2017
Intracranial 4D flow magnetic resonance imaging reveals altered haemodynamics in sickle cell diseaseLena Václavů, Zelonna A V Baldew, Sanna Gevers, et al.JMIR Human Factors|September 3, 2024
Toward Personalized Care and Patient Empowerment and Perspectives on a Personal Health Record in Hemophilia Care: Qualitative Interview StudyMartijn R Brands, Lotte Haverman, Jelmer J Muis, et al.Therapeutic Advances in Hematology|October 9, 2024
Future needs for continuing innovation in hemophilia: improving outcomes for individuals of all severities, including women and those in resource-constrained regionsJan Blatný, Jan Astermark, Cristina Catarino, et al.Pageof 16